Bentley Pharmaceuticals to Release Fourth Quarter and Year End 2004 Fi

    Business Editors

    EXETER, N.H.--(BUSINESS WIRE)--March 4, 2005--Bentley Pharmaceuticals, Inc. (NYSE:BNT), a technology-based specialty pharmaceutical and drug delivery company with a growing branded and generic product line in Europe, announced today that it will release its fourth quarter and year-end results before the open of the market on Tuesday, March 8, 2005.

    Management will host a conference call on the same day at 10 a.m. EST to discuss the results. To participate on the live call, please dial 800-884-5695 from the U.S. or, for international callers, please dial 617-786-2960 (passcode #10092450), approximately 15 minutes before the start time. A telephone replay will be available for 30 days by dialing 888-286-8010 from the U.S. or, 617-801-6888 for international callers (passcode #37129206). To listen to the conference call live via the Internet, visit Bentley's web site at www.bentleypharm.com. Please go to the web site 15 minutes prior to its start to register, download, and install the necessary audio software. A replay will be available on Bentley's web site for 30 days.

    Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on advanced drug delivery technologies and pharmaceutical products. Bentley's proprietary drug technologies enhance or facilitate the absorption of pharmaceutical compounds across various membranes. Bentley also manufactures and markets a growing portfolio of generic and branded pharmaceuticals in Europe for the treatment of cardiovascular, gastrointestinal, infectious and neurological diseases through its subsidiaries, Laboratorios Belmac, Laboratorios Davur and Laboratorios Rimafar; and manufactures and markets active pharmaceutical ingredients through its subsidiary, Bentley API.

    Copies of Bentley Pharmaceuticals' press releases and other information may be obtained through Bentley's web site at www.bentleypharm.com.

--30--VS/cg*

CONTACT: Bentley Pharmaceuticals, Inc. Michael D. Price, 603-658-6100 www.bentleypharm.com or Investor Relations Contacts: Porter, Le Vay & Rose, Inc. Linda Decker (Investor Relations), 212-564-4700 Jeff Myhre (Editorial), 212-564-4700 Tom Gibson (Media Relations), 201-476-0322

KEYWORD: NEW HAMPSHIRE INDUSTRY KEYWORD: PHARMACEUTICAL MEDICAL EARNINGS CONFERENCE CALLS SOURCE: Bentley Pharmaceuticals, Inc.

Copyright Business Wire 2005